Safety profile of combined therapy inhibiting EFGR and VEGF pathways in patients with advanced non-small-cell lung cancer: A meta-analysis of 15 phase II/III randomized trials-Reference-Cited by-同舟云学术

Safety profile of combined therapy inhibiting EFGR and VEGF pathways in patients with advanced non-small-cell lung cancer: A meta-analysis of 15 phase II/III randomized trials

Published:2014-12-12 Issue:2 Volume:137 Page:409-419
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ma Wang¹,Xu Mingxin²,Liu Yiqian³,Liu Hao⁴,Huang Jiale²,Zhu Yanjie²,Ji Li-juan⁵,Qi Xiaolong¹²

Affiliation:

1. Department of Oncology; The First Affiliated Hospital of Zhengzhou University; Zhengzhou China

2. Department of Gastroenterology; Tongji Hospital, Tongji University School of Medicine; Shanghai China

3. Department of Oncology; The First Affiliated Hospital with Nanjing Medical University; Nanjing China

4. Department of Medical Sciences; Biology and Biomedical Sciences, Harvard Medical School; Boston MA

5. Department of Rehabilitation; The Second People's Hospital of Huai'an; Huai'an China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Cancer statistics, 2014;Siegel;Cancer,2014

2. SEER Cancer Statistics Review;N;National Cancer Institute,1975-2011

3. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

4. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

5. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Tyrosine Kinase Inhibitors in Reduction of Mortality from Non-small Cell Lung Cancer: A Meta-analysis;Combinatorial Chemistry & High Throughput Screening;2023-04

2. A novel quantitative prognostic model for initially diagnosed non-small cell lung cancer with brain metastases;Cancer Cell International;2022-08-11

3. Knockdown of PLAT enhances the anticancer effect of gefitinib in non-small cell lung cancer;Journal of Thoracic Disease;2020-03

4. Vascular endothelial growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small cell lung cancer;Expert Opinion on Pharmacotherapy;2020-01-20

5. Potential Successes and Challenges of Targeted Cancer Therapies;JNCI Monographs;2019-08-01